Nasdaq

Medtronic Receives Approval for U.S. Labeling of the Intellis™ Platform Showing Superior Back Pain Relief When Using DTM™ Spinal Cord Stimulation

Revised Commercial Labeling to Reflect Outcomes of a Randomized Controlled Trial Demonstrating Superiority of DTM™ Spinal Cord Stimulation (SCS) Compared to Conventional SCS for the Treatment of ...
Nasdaq

DTM™ Spinal Cord Stimulation Using the Medtronic Intellis™ Platform Shows Superior Back Pain Relief Compared to Conventional SCS Therapy in an RCT

At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Reliefof at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater1 The RCT demonstrated profound pain relief and ...
Pharmabiz

Medtronic gets US FDA revised commercial labeling approval for Intellis platform with DTM to treat chronic, intractable back and leg pain

Medtronic announced the US Food and Drug Administration (FDA) has approved revised commercial labeling for the Intellis Platform with Differential Target Multiplexed (DTM) programming for the ...
JD Supra

Medtronic Pain Management Device Approved by FDA

Medtronic announced FDA approval and U.S. launch of its Intellis Platform for the management of certain types of chronic intractable pain. According to Medtronic, the Intellis platform features the ...
News Medical

Medtronic launch spinal chord stimulation platform for chronic pain management following FDA approval

Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome ...
health.economictimes.indiatimes

Medtronic India announces first procedure with Intellis spinal cord stimulation platform

Mumbai: Medtronic Private Limited announced the first clinical procedure in India with the Intellis spinal cord stimulation (SCS) platform. The stimulator is the world’s smallest SCS device for the ...
Pharmabiz

Medtronic introduces Intellis rechargeable spinal cord stimulator in India for chronic pain management

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, a global leader in healthcare technology, has announced the first clinical procedure in India with the Intellis spinal cord ...
It News Online

First Procedure in India Performed With Intellis™ Rechargeable Spinal Cord Stimulator for Chronic Pain Management

First patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator India Medtronic Private Limited, a wholly owned ...
News Medical

Medtronic: RCT demonstrates profound back pain relief with DTM therapy

Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial (RCT) showing statistically significant (p=0.0009) and superior back pain relief with ...
JD Supra

Medtronic’s Intellis and Vanta Neurostimulators Receive FDA Approval for DPN

Medtronic announced that its Intellis™ neurostimulator and the Vanta™ neurostimulator have both received approval from the U.S. Food and Drug Administration (FDA) for the treatment of chronic pain ...
Stockhouse

Medtronic Receives Approval for U.S. Labeling of the Intellis(TM) Platform Showing Superior Back Pain Relief When Using DTM(TM) Spinal Cord Stimulation

DUBLIN , March 17, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial ...